Solt DB Biotech Company DB /
Lyell Immunopharma

Lyell Immunopharma

Operating Overview

Year Founded

2018

Country

United States

Operating Status

Active

Genesis

Startup

Former Name(s)

Incubator or Accelerator

Taxonomy

Bioeconomy Sector

Biopharma

Sector Focus

Drug Development

Tags

Autologous

CAR-T

Cell Therapy

Epigenetics

TILs

Equity Type

Public

Stock Symbol

Nasdaq: LYEL

Explore